A. S. Demir, S. Basceken / Tetrahedron: Asymmetry 24 (2013) 1218–1224
1223
extracts were dried over anhydrous sodium sulfate and concen-
trated in vacuo after filtration. Purification by column chroma-
tography (silica gel, ethyl acetate–hexane as an eluent) gave
Spectroscopic data are in agreement with the published data. The
enantiomeric excess was determined by HPLC with an AS-H col-
umn (i-PrOH/hexanes: 5/95, flow rate: 1.0 mL/min, k = 230 nm,
(
2R)-2-anilinoxy alcohol. The enantiomeric excess (ee) of the prod-
anti/syn = 13/87); t
R
= 53.1 min (minor) and t
R
= 77.3 min (major).
1
ucts was determined by chiral-phase HPLC analysis. The absolute
configurations of the products were determined by comparing
the values with those previously reported in the literature.
H NMR (CDCl ): d 9.68 (d, J = 1.7 Hz, 1H), 7.08 (d, J = 8.7 Hz, 2H),
3
6.86 (d, J = 8.7, Hz, 2H), 4.78–4.72 (m, 1H), 4.64 (dd, J = 9.5,
12.6 Hz, 1H), 3.76 (s, 3H), 2.79–2.68 (m, 1H), 0.98 (d, J = 7.3 Hz,
1
8
1
3
3
H); C NMR (CDCl
3
): d 202.5, 159.3, 129.2, 114.4, 78.4, 55.2,
4
.3. Thioureas I and II are known compounds:7
48.6, 43.4, 12.0.
0
0
0
1
,1 -([2,2 -Bipyridine]-4,4 -diyl)bis(3-(3,5-bis(trifluoromet-
4.7. (2R,3S)-3-(2-Methoxyphenyl)-2-methyl-4-nitrobutyral-
dehyde 3d
1
hyl)phenyl)thiourea) I: H NMR (CD
3
COCD
3
): d 10.1 (br s, 2H), 8.6
(
(
1
app d, J = 2.0 Hz, 2H), 8.5 (app d, J = 5.5 Hz, 2H), 8.3 (app s, 4H), 7.9
app dd, J = 2.0, 5.5 Hz, 2H), 7.8 (app s, 2H); 13C NMR (CD
The title compound was prepared from trans-2-methoxy-b-
nitrostyrene 2d and propionaldehyde 1a according to the general
procedure; compound 3d was obtained with a maximum of 97%
ee. Spectroscopic data are in agreement with the published data.
The enantiomeric excess was determined by HPLC with an OD-H
column (i-PrOH/hexanes: 5/95, flow rate: 0.5 mL/min, k = 220 nm,
3
3
COCD ): d
0
81.1 (s, C@S), 150.7 (s, bipyridine-C-4, bipyridine-C-4 ), 142.2 (s,
0
ArC-NHR), 132.7 (d, bipyridine-C-6, bipyridine-C-6 ), 132.3, 131.9
s, ArC-CF ), 125.7 (s, C-F), 124.9, 122.9, 118.8, 117.3, 114.2 (d,
Ar-C).
(
3
0
0
0
1
,1 -([2,2 -Bipyridine]-4,4 -diylbis(methylene))bis(3-(3,5-
1
R R
= 39.9 min (minor); t H
= 41.4 min (major). 1
bis(trifluoromethyl)phenyl)thiourea) II: H NMR (CD
br s, 2H), 8.6 (app d, J = 5.0 Hz, 2H), 8.5 (app s, 2H), 8.4 (app d,
J = 4.8 Hz, 4H), 7.7 (app s, 2H), 7.4 (app dd, J = 1.5, 5.0 Hz, 2H),
3
3
COCD ): d 9.8
anti/syn = 9/91); t
NMR (CDCl ): d 9.70 (d, J = 1.8 Hz, 1H), 7.28-7.24 (m, 1H), 7.06
(
3
(dd, J = 1.7, 7.5 Hz, 1H), 6.92–6.87 (m, 2H), 4.85 (dd, J = 9.0,
5
.07 (app d, J = 4.8 Hz, 4H); 13C NMR (CD
3
COCD
3
): d 183.2 (s,
12.6 Hz, 1H), 4.73 (dd, J = 9.0, 12.6 Hz, 1H), 3.82 (s, 3H), 3.02–
0
13
C@S), 156.9 (s, bipyridine-C-2, bipyridine-C-2 ), 150.1 (d, bipyri-
dine-C-6, bipyridine-C-6 ), 149.7 (s, bipyridine-C-4, bipyridine-C-
4
1
3
2.98 (m, 1H), 0.92 (d, J = 7.3 Hz, 3H). C NMR (CDCl ): d 202.9,
0
157.4, 130.3, 129.3, 124.5, 120.9, 111.1, 77.5, 55.3, 47.1, 40.6, 12.1.
0
3
), 142.8 (s, ArC-NHR), 132.2, 131.9 (s, ArC-CF ), 128.4 (d, Ar-C),
25.7 (s, C-F), 123.8, 123.5, 123.0, 120.2, 117.8 (d, Ar-C), 47.6 (t,
R).
4.8. (2R,3S)-(2-Bromophenyl)-2-methyl-4-nitrobutyraldehyde
(3e)
Ar-CH
2
4
.4. (2R,3S)-2-Methyl-4-nitro-3-phenylbutyraldehyde 3a
The title compound was prepared from trans-2-bromo-b-nitro-
styrene 2e and propionaldehyde 1a according to the general proce-
dure; compound 3e was obtained with a maximum of 98% ee.
Spectroscopic data are in agreement with the published data. The
enantiomeric excess was determined by HPLC with an AD-H col-
umn (i-PrOH/hexanes: 5/95, flow rate: 0.5 mL/min, k = 220 nm,
The title compound was prepared from trans-b-nitrostyrene 2a
and propionaldehyde 1a according to the general procedure; com-
pound 3a was obtained with a maximum of 93% ee. Spectroscopic
data are in agreement with the published data. The enantiomeric
excess was determined by HPLC with an OD-H column (i-PrOH/
anti/syn = 18/82); t
H NMR (CDCl
3
R
= 23.4 min (major) and t
): d 9.73 (d, J = 1.5 Hz, 1H), 7.57–7.62 (m, 1H),
7.34–7.27 (m, 1H), 7.23–7.14 (m, 2H), 4.88–4.72 (m, 2H), 2.98–
R
= 27.4 min (minor).
1
hexanes: 10/90; flow rate: 1.0 mL/min; k = 220 nm, anti/syn = 18/
1
8
(
(
2); t
CDCl
m, 2H), 4.78 (dd, J = 5.5, 12.7 Hz, 1H), 4.67 (dd, J = 9.5, 12.7 Hz,
R
= 22.2 min (minor) and t
R
= 31,4 min (major). H NMR
1
3
3
): d 9.68 (d, J = 1.6 Hz, 1H), 7.35–7.26 (m, 3H), 7.17–7.15
3
2.91 (m, 1H), 1.04 (d, J = 7.4 Hz, 3H); C NMR (CDCl ): d 201.9,
136.4, 133.9, 129.5, 128.2, 75.5, 48.0, 12.3.
1
3
4
H), 3.85–3.77 (m, 1H), 2.84–2.72 (m, 1H), 0.97 (d, J = 7.3 Hz,
H); 1 C NMR (CDCl
3
): d 202.4, 136.7, 129.1, 128.1, 78.2, 48.4,
4.9. (2R,3S)-2-Ethyl-4-nitro-3-(4-bromophenyl)butyraldehyde
3f
3
4.0, 12.1.
4
3
.5. (2R,3S)-3-(4-Bromophenyl)-2-methyl-4-nitrobutyraldehyde
b
The title compound was prepared from trans-4-bromo-b-nitro-
styrene 2b and butyraldehyde 1b according to the general proce-
dure; compound 3f was obtained with a maximum of 92% ee.
Spectroscopic data are in agreement with the published data. The
enantiomeric excess was determined by HPLC with an AD-H (i-
PrOH/hexanes: 1/99, flow rate: 1.0 mL/min, k = 220 nm, anti/
The title compound was prepared from trans-4-bromo-b-nitro-
styrene 2b and propionaldehyde 1a according to the general proce-
dure; compound 3b was obtained with a maximum of 97% ee.
Spectroscopic data are in agreement with the published data. The
enantiomeric excess was determined by HPLC with an AD-H col-
umn (i-PrOH/hexanes: 2/98, flow rate: 0.8 mL/min, k = 220 nm,
R R
= 22.2 min (major) and t H
= 31.3 min (minor). 1
syn = 8/92); t
NMR (CDCl ): d 9.68 (d, J = 2.3 Hz, 1H), 7.47 (d, J = 8.5 Hz, 2H),
3
7.08 (d, J = 8.5 Hz, 2H), 4.73 (dd, J = 4.8, 12.8 Hz, 1H), 4.58 (dd,
anti/syn = 33/67); t
R
= 34.9 min (major) and t
): d 9.69 (d, J = 1.4 Hz, 1H), 7.48 (d, J = 8.4 Hz, 2H),
.06 (d, J = 8.4 Hz, 2H), 4.78 (dd, J = 5.2, 12.8 Hz, 1H), 4.66 (dd,
J = 9.6, 12.8 Hz, 1H), 3.84–3.76 (m, 1H), 2.83–2.73 (m, 1H), 1.01
R
= 49.9 min (minor).
J = 9.9, 12.8 Hz, 1H), 3.82–3.75 (m, 1H), 2.69–2.63 (m, 1H), 1.56–
1.42 (m, 2H), 0.81 (t, J = 7.5 Hz, 3H); C NMR (CDCl ): d 202.8,
3
136.0, 132.3, 129.8, 122.1, 78.3, 54.6, 43.3, 42.1, 20.3, 10.5.
1
13
H NMR (CDCl
3
7
1
3
(
d, J = 7.3 Hz, 3H); C NMR (CDCl
3
): d 201.8, 135.7, 132.3, 129.8,
4.10. (2R,3S)-2-(Methylethyl)-4-nitro-3-(4-bromophenyl)butyr-
1
22.2, 77.8, 48.2, 43.5, 12.2.
aldehyde 3g
4
.6. (2R,3S)-3-(4-Methoxyphenyl)-2-methyl-4-nitrobutyral-
The title compound was prepared from trans-4-bromo-b-nitro-
styrene 2b and isovaleraldehyde 1c according to the general proce-
dure; compound 3g was obtained with a maximum of 95% ee.
Spectroscopic data are in agreement with the published data. The
enantiomeric excess was determined by HPLC with an AD-H col-
umn (i-PrOH/hexanes: 5/95, flow rate: 0.5 mL/min, k = 220 nm,
dehyde 3c
The title compound was prepared from trans-4-methoxy-b-
nitrostyrene 2c and propionaldehyde 1a according to the general
procedure; compound 3c was obtained in a maximum of 90% ee.